New Zika Guidelines for Florida as Vaccine Research Progresses

Important research is happening locally and across the country in an attempt to control the Zika virus.

The National Institutes of Health on Wednesday announced the first human trial of a Zika vaccine, while the Argonne National Laboratory Advanced Photon Source has allowed researchers to examine the molecular structure of the virus to help find a vaccine.

Thanks to our sponsors:

View all sponsors

Meanwhile, the CDC recently warned pregnant women to stay away from a Miami neighborhood to avoid getting Zika.

And all this while the Olympics are set to open in Brazil, one of the countries hardest hit by the virus and its associated birth defects. 

Joining host Eddie Arruza for an update on Zika are Dr. Allison Arwady, an infectious disease specialist and Chief Medical Officer of the Chicago Department of Public Health; and Bob Fischetti, Argonne's Life Sciences Advisor to the Advanced Photon Source.

Sign up for our morning newsletter to get all of our stories delivered to your mailbox each weekday.

Related Stories

For Expectant Mother, Possible Exposure to Zika a Terrifying Ordeal

April 26: The Zika virus has been shown to cause microcephaly and other fetal brain abnormalities. We talk with a local woman, pregnant with her first child, who has been dealing with the terrifying possibility that she and her unborn child may have been exposed to the virus.

First Zika Case Confirmed in Chicago

Feb. 29: The city on Monday morning confirmed the first case of Zika virus. The patient, who was identified as a woman in her 30s, visited Presence Saint Joseph Hospital after returning from a trip to Columbia with symptoms consistent with the virus.

Zika Virus Raises Concern for Chicago Travelers

Feb. 2: The World Health Organization declared the Zika virus an international public health emergency. Dr. Allison Arwady, chief medical officer of the Chicago Department of Public Health, joins us to discuss the virus and the risk it poses to Chicago jet-setters.

Thanks to our sponsors:

View all sponsors

Thanks to our sponsors:

View all sponsors